Stock DNA
Computers - Software & Consulting
USD 673 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.91
-999,999.00%
3.10
Revenue and Profits:
Net Sales:
68 Million
(Quarterly Results - Sep 2025)
Net Profit:
-3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-19.67%
0%
-19.67%
6 Months
-42.13%
0%
-42.13%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Omada Health, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
41.82%
EBIT Growth (5y)
29.77%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
52.01%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.77
EV to EBIT
-44.30
EV to EBITDA
-54.23
EV to Capital Employed
59.74
EV to Sales
5.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-134.85%
ROE (Latest)
-14.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
Bollinger Bands
Mildly Bearish
KST
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 10 Schemes (6.78%)
Foreign Institutions
Held by 13 Foreign Institutions (2.14%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
68.00
61.40
10.75%
Operating Profit (PBDIT) excl Other Income
-1.20
-3.00
60.00%
Interest
0.40
1.10
-63.64%
Exceptional Items
-2.30
-0.70
-228.57%
Consolidate Net Profit
-3.20
-5.30
39.62%
Operating Profit Margin (Excl OI)
-36.90%
-70.80%
3.39%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 10.75% vs 11.64% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 39.62% vs 43.62% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
169.80
122.80
38.27%
Operating Profit (PBDIT) excl Other Income
-38.90
-61.50
36.75%
Interest
4.50
4.70
-4.26%
Exceptional Items
0.20
-2.60
107.69%
Consolidate Net Profit
-47.10
-67.50
30.22%
Operating Profit Margin (Excl OI)
-257.10%
-537.50%
28.04%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 38.27% vs 37.67% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 30.22% vs 6.90% in Dec 2023






